Recruiting Multiple Myeloma Studies in Bridgeton
About Multiple Myeloma Clinical Trials in Bridgeton
Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.
There are currently 1 multiple myeloma clinical trials recruiting participants in Bridgeton, MO. These studies are seeking a combined 200 participants. Research is being sponsored by GlaxoSmithKline. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Myeloma Clinical Trials in Bridgeton — FAQ
Are there multiple myeloma clinical trials in Bridgeton?
Yes, there are 1 multiple myeloma clinical trials currently recruiting in Bridgeton, MO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Bridgeton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bridgeton research site will contact you about next steps.
Are clinical trials in Bridgeton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bridgeton studies also compensate for your time and travel.
What multiple myeloma treatments are being tested?
The 1 active trials in Bridgeton are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.
Data updated July 13, 2026 from ClinicalTrials.gov